Clinical efficacy and safety of telitacicept combined with methotrexate in the treatment of rheumatoid arthritis
American Journal of Translational Research · 2026 · 18 (4) · 3220-3229
DOI: 10.62347/pkwi2684 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Yan Tao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine Wuhan 430015, Hubei, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine Wuhan 430015, Hubei, China.
- Department of Radiology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine Wuhan 430015, Hubei, China.
Zitieren
APA
Tao, Y., Zhang, J., Li, H., Zhou, J., & Wu, M. (2026). Clinical efficacy and safety of telitacicept combined with methotrexate in the treatment of rheumatoid arthritis. American Journal of Translational Research, 18(4), 3220-3229. https://doi.org/10.62347/pkwi2684
Vancouver
Tao Y, Zhang J, Li H, Zhou J, Wu M. Clinical efficacy and safety of telitacicept combined with methotrexate in the treatment of rheumatoid arthritis. American Journal of Translational Research. 2026;18(4):3220-3229. doi:10.62347/pkwi2684
BibTeX
@article{Tao2026,
author = {Tao, Yan and Zhang, Jun and Li, Hang and Zhou, Jian and Wu, Meng},
title = {Clinical efficacy and safety of telitacicept combined with methotrexate in the treatment of rheumatoid arthritis},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {4},
pages = {3220--3229},
doi = {10.62347/pkwi2684}
}
EUVIMED